Severe Sleep Apnea Linked to Elevated Tau Protein in Middle-Aged Men

A pilot study in Chronic Diseases and Translational Medicine has found that middle-aged men with severe obstructive sleep apnea show elevated levels of plasma total tau—a protein strongly associated with Alzheimer's disease and neurodegeneration—along with lower cognitive scores on memory testing. The researchers correlated these biomarkers with objective sleep quality measurements, suggesting that chronic sleep disruption may be driving tau accumulation and cognitive decline even in midlife. This is significant because tau elevation typically precedes clinical dementia by years or decades, raising the possibility that treating sleep apnea could be a practical intervention to reduce Alzheimer's risk. While this is a small pilot study and needs replication in larger, diverse cohorts including women, it adds to growing evidence that sleep quality is not just a symptom but a modifiable driver of brain aging. For the millions with untreated sleep apnea, this study reinforces that CPAP or other interventions may offer cognitive protection beyond just improving daytime alertness and cardiovascular health.